Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 6T4O391P5Y

Structure

InChI Key FJCDSQATIJKQKA-UHFFFAOYSA-N
Smile Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1
InChI
InChI=1S/C22H18FN7/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23/h2-10,12-13,24H,11H2,1H3,(H,28,29)

Physicochemical Descriptors

Property Name Value
Molecular Formula C22H18FN7
Molecular Weight 399.43
AlogP 4.24
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 5.0
Polar Surface Area 83.79
Molecular species NEUTRAL
Aromatic Rings 5.0
Heavy Atoms 30.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR TGF-beta receptor type I inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Myeloproliferative Disorders 2 D009196 ClinicalTrials
Myelodysplastic Syndromes 1 D009190 ClinicalTrials
Osteosarcoma 1 D012516 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Desmoid Tumors 1 D018222 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3260567
DrugBank DB15310
FDA SRS 6T4O391P5Y
Guide to Pharmacology 8107
SureChEMBL SCHEMBL250076
ZINC ZINC000113391423